SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN ERYTHRODERMIC CUTANEOUS T-CELL LYMPHOMA CORRELATE WITH RESPONSE TO PHOTOPHERESIS-BASED TREATMENT

被引:10
作者
GOLDMAN, BD
OH, SK
DAVIS, BE
KADIN, ME
POIESZ, BJ
KOH, HK
机构
[1] BOSTON UNIV, SCH MED, DEPT DERMATOL, BOSTON, MA 02118 USA
[2] BOSTON UNIV, SCH MED, DEPT MICROBIOL, BOSTON, MA 02118 USA
[3] BOSTON UNIV, SCH MED, DEPT MED, BOSTON, MA 02118 USA
[4] BOSTON UNIV, SCH MED, DEPT EPIDEMIOL & BIOSTAT, BOSTON, MA 02118 USA
[5] BOSTON UNIV, SCH PUBL HLTH, BOSTON, MA 02215 USA
[6] BETH ISRAEL HOSP, DEPT PATHOL, BOSTON, MA 02215 USA
[7] SUNY, DEPT HEMATOL ONCOL, SYRACUSE, NY USA
关键词
D O I
10.1001/archderm.129.9.1166
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: T-cell lymphoma (CTCL) comprises a spectrum of presentations, including erythroderma, pruritus, lymphadenopathy, and circulating atypical lymphocytes. Photopheresis is an extracorporeal treatment in which white blood cell concentrates are subjected to UV irradiation when the serum methoxypsoralen level is above 50 ng/mL. Of patients with CTCL, those with erythroderma have been most responsive to this therapy. In some conditions, including certain malignant hematologic neoplasms, serum soluble interleukin 2 receptor levels (SIL2R) correlate with disease activity. We sought to determine whether serum SIL2R levels correlated with disease activity in six erythrodermic patients with CTCL treated primarily with photopheresis. We measured SIL2R levels in five patients with stage III or greater erythrodermic CTCL and one with stage IIa CTCL. We compared SIL2R values with clinical course, skin scores, CD4/CD8 ratios, peripheral white blood cell counts, and Sezary cell counts, using Pearson correlation coefficients. Observations: The SlL2R levels correlated with clinical course and skin scores, even when controlled for other factors noted above. Conclusions: Data preliminarily suggest that serum SIL2R levels may be useful indicators of disease activity in erythrodermic CTCL patients treated with photopheresis.
引用
收藏
页码:1166 / 1170
页数:5
相关论文
共 29 条
[1]  
APPINO A, 1992, J INVEST DERMATOL, V98, P546
[2]   THYMOPENTIN IN SEZARY-SYNDROME [J].
BERNENGO, MG ;
APPINO, A ;
BERTERO, M ;
NOVELLI, M ;
FIERRO, MT ;
DOVEIL, GC ;
LISA, F .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (17) :1341-1346
[3]   SOLUBLE INTERLEUKIN-2 RECEPTOR IN SEZARY-SYNDROME - ITS ORIGIN AND CLINICAL-APPLICATION [J].
BERNENGO, MG ;
FIERRO, MT ;
NOVELLI, M ;
LISA, F ;
APPINO, A .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (02) :124-129
[4]  
DUMMER R, 1991, EUR J DERMATOL, V1, P135
[5]   TREATMENT OF CUTANEOUS T-CELL LYMPHOMA BY EXTRACORPOREAL PHOTOCHEMOTHERAPY - PRELIMINARY-RESULTS [J].
EDELSON, R ;
BERGER, C ;
GASPARRO, F ;
JEGASOTHY, B ;
HEALD, P ;
WINTROUB, B ;
VONDERHEID, E ;
KNOBLER, R ;
WOLFF, K ;
PLEWIG, G ;
MCKIERNAN, G ;
CHRISTIANSEN, I ;
OSTER, M ;
HONIGSMANN, H ;
WILFORD, H ;
KOKOSCHKA, E ;
REHLE, T ;
PEREZ, M ;
STINGL, G ;
LAROCHE, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (06) :297-303
[6]   THE HUMAN INTERLEUKIN-2 RECEPTOR - NORMAL AND ABNORMAL EXPRESSION IN T-CELLS AND IN LEUKEMIAS INDUCED BY THE HUMAN T-LYMPHOTROPIC RETROVIRUSES [J].
GREENE, WC ;
LEONARD, WJ ;
DEPPER, JM ;
NELSON, DL ;
WALDMANN, TA .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (04) :560-572
[7]  
HARRINGTON DS, 1988, ARCH PATHOL LAB MED, V112, P597
[8]   INTERLEUKIN-2 RECEPTOR BETA-CHAIN GENE - GENERATION OF 3 RECEPTOR FORMS BY CLONED HUMAN ALPHA-CHAIN AND BETA-CHAIN CDNAS [J].
HATAKEYAMA, M ;
TSUDO, M ;
MINAMOTO, S ;
KONO, T ;
DOI, T ;
MIYATA, T ;
MIYASAKA, M ;
TANIGUCHI, T .
SCIENCE, 1989, 244 (4904) :551-556
[9]  
JACQUES Y, 1990, J BIOL CHEM, V265, P20252
[10]   DYNAMIC CHANGES IN SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS AFTER LUNG OR HEART-LUNG TRANSPLANTATION [J].
LAWRENCE, EC ;
HOLLAND, VA ;
YOUNG, JB ;
WINDSOR, NT ;
BROUSSEAU, KP ;
NOON, GP ;
WHISENNAND, HH ;
DEBAKEY, ME ;
NELSON, DL .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (03) :789-796